Knowlton Amy R, Arnsten Julia H, Gourevitch Marc N, Eldred Lois, Wilkinson James D, Rose Carol Dawson, Buchanan Amy, Purcell David W
Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
J Acquir Immune Defic Syndr. 2007 Nov 1;46 Suppl 2:S110-9. doi: 10.1097/QAI.0b013e31815767f8.
Active injection drug users (IDUs) are at high risk of unsuccessful highly active antiretroviral therapy (HAART). We sought to identify baseline factors differentiating IDUs' treatment success versus treatment failure over time among those taking HAART. Interventions for Seropositive Injectors-Research and Evaluation (INSPIRE) study participants were assessed at baseline and at 6- and 12-month follow-ups. Multinominal regression determined baseline predictors of achieving or maintaining viral suppression relative to maintaining detectable viral loads over 12 months. Of 199 participants who were retained and remained on HAART, 133 (67%) had viral load change patterns included in the analysis. At follow-up, 66% maintained detectable viral loads and 15% achieved and 19% maintained viral suppression. Results indicated that those having informal care (instrumental or emotional support) were 4.6 times more likely to achieve or maintain viral suppression relative to experiencing treatment failure. Those who maintained viral suppression were 3.5 times less likely to live alone or to report social discomfort in taking HAART. Study results underscore the importance of microsocial factors of social network support, social isolation, and social stigma for successful HAART outcomes among IDUs. The findings suggest that adherence interventions for IDUs should promote existing informal HIV caregiving, living with supportive others, and positive medication-taking norms among social networks.
注射毒品的活跃使用者(IDU)接受高效抗逆转录病毒疗法(HAART)治疗失败的风险很高。我们试图确定在接受HAART治疗的人群中,随着时间推移区分IDU治疗成功与治疗失败的基线因素。对血清反应阳性注射者进行研究与评估(INSPIRE)的参与者在基线以及6个月和12个月随访时接受了评估。多项回归分析确定了相对于在12个月内维持可检测病毒载量而言,实现或维持病毒抑制的基线预测因素。在199名继续接受HAART治疗的参与者中,133名(67%)的病毒载量变化模式纳入了分析。随访时,66%的人维持可检测病毒载量,15%的人实现了病毒抑制,19%的人维持了病毒抑制。结果表明,获得非正式照料(工具性或情感支持)的人相对于治疗失败而言,实现或维持病毒抑制的可能性高4.6倍。维持病毒抑制的人独自生活或报告在接受HAART治疗时存在社交不适的可能性低3.5倍。研究结果强调了社会网络支持、社会隔离和社会耻辱感等微观社会因素对IDU成功接受HAART治疗结果的重要性。研究结果表明,针对IDU的依从性干预措施应促进现有的非正式HIV护理、与支持自己的人一起生活以及在社会网络中形成积极的服药规范。